Clinigen Group Plc (CLIN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2011 | 06-2010 | |
| Cash Flows From Operating Activities | ||
| Accounts receivable | -2,452 | -275 |
| Other Working Capital | 4,554 | -1,803 |
| Other Operating Activity | 10,151 | 1,140 |
| Operating Cash Flow | $12,253 | $-938 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -4,013 | -1,384 |
| Net Acquisitions | N/A | -1,000 |
| Investing Cash Flow | $-4,013 | $-2,384 |
| Cash Flows From Financing Activities | ||
| Debt Issued | N/A | 2,675 |
| Debt Repayment | -455 | N/A |
| Dividend Paid | N/A | -1,100 |
| Financing Cash Flow | $-455 | $1,575 |
| Exchange Rate Effect | 19 | N/A |
| Beginning Cash Position | 1,027 | 3,047 |
| End Cash Position | 8,831 | 1,300 |
| Net Cash Flow | $7,785 | $-1,747 |
| Free Cash Flow | ||
| Operating Cash Flow | 12,253 | -938 |
| Capital Expenditure | -4,013 | -1,384 |
| Free Cash Flow | 8,240 | -2,322 |